
Retatrutide — 10 mg
An investigational peptide analogue studied in activity models involving GIP, GLP-1 and glucagon receptors.
10 mg
For research use only (RUO). Not for use in humans. Commercial availability is conditional on legal-status confirmation and buyer-eligibility verification.
25 products listed

An investigational peptide analogue studied in activity models involving GIP, GLP-1 and glucagon receptors.
10 mg

A 20 mg configuration of the investigational peptide analogue studied in multi-receptor models.
20 mg

A mitochondrial-derived peptide used in research on energy signalling and cellular responses.
10 mg

A research coenzyme involved in redox reactions and cellular metabolism. It is classified separately from peptides.
500 mg

A 1,000 mg configuration of the NAD+ coenzyme, intended solely for documented laboratory use.
1,000 mg

A research tetrapeptide associated with preclinical studies of mitochondrial membranes and oxidative stress.
10 mg

A synthetic growth-hormone-releasing hormone analogue listed as a research material with legal status under review.
10 mg

A synthetic fragment corresponding to a region of the human growth hormone sequence; identity must be confirmed by batch documentation.
5 mg

A copper–tripeptide complex used in laboratory models concerning signalling and the extracellular matrix.
50 mg

A 100 mg configuration of the GHK-Cu complex for laboratory research use only.
100 mg

A synthetic 15-amino-acid peptide investigated in preclinical tissue-signalling models.
5 mg

A 10 mg configuration of BPC-157, listed solely for assessment and preclinical research.
10 mg

A commercial material associated with thymosin beta-4-derived sequences. Sequence and identity must be verified for every batch.
5 mg

A 10 mg configuration; the declared sequence and identification method must be confirmed in the batch documentation.
10 mg

A declared multi-component blend. The identity and quantity of every component must be supported separately by batch documentation.
BPC-157 10 mg + GHK-Cu 50 mg + TB-500 5 mg

A declared four-component blend. Commercial release requires individual and combined composition verification.
BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg + KPV 10 mg

A research peptide analogue presented without the DAC complex; the exact chemical form must be confirmed in the batch documentation.
10 mg

A synthetic pentapeptide studied in preclinical models of ghrelin secretagogue-receptor activity.
10 mg

A protein substance associated with authorised medicines in certain contexts. Sale is blocked pending legal classification and authorised-supply-chain verification.
10 IU

A modified IGF-1 analogue used as a research material in cellular-signalling models.
1 mg

A synthetic peptide associated with melanocortin-receptor activity. Its status as a medicinal substance in some jurisdictions requires legal review.
10 mg

A modified Semax peptide variant listed for laboratory neurobiological models; the exact form must be analytically verified.
10 mg

A modified Selank peptide variant for neurobiological research; identity and terminal form require batch confirmation.
10 mg

A nonapeptide described in historical sleep research. Experimental relevance depends on material identity and the model used.
10 mg

An ancillary laboratory solution. Composition, sterility, preservative and permitted use will not be stated until supplier documentation has been verified.
3 mL
Try another name or remove the filters.
The content and catalogue are intended for eligible professionals, laboratories and research organisations.
Read the full noticeReceive a code for the first order that passes eligibility and legal-availability checks.